טוען...
An antigen-encapsulating nanoparticle platform for T(H)1/17 immune tolerance therapy
Tolerogenic nanoparticles (NPs) are rapidly being developed as specific immunotherapies to treat autoimmune disease. However, many NP-based therapies conjugate antigen (Ag) directly to the NP posing safety concerns due to antibody binding or require the co-delivery of immunosuppressants to induce to...
שמור ב:
| הוצא לאור ב: | Nanomedicine |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5237397/ https://ncbi.nlm.nih.gov/pubmed/27720992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2016.09.007 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|